Suppr超能文献

全身性皮质类固醇疗法——副作用及其处理

Systemic corticosteroid therapy--side effects and their management.

作者信息

Stanbury R M, Graham E M

机构信息

Medical Eye Unit, St Thomas's Hospital, London.

出版信息

Br J Ophthalmol. 1998 Jun;82(6):704-8. doi: 10.1136/bjo.82.6.704.

Abstract

The anti-inflammatory effects of corticosteroids cannot be separated from their metabolic effects as all cells use the same glucocorticoid receptor; therefore when corticosteroids are prescribed measures should be taken to minimise their side effects. Clearly, the chance of significant side effects increases with the dose and duration of treatment and so the minimum dose necessary to control the disease should be given. Before embarking on a long term course of corticosteroids the factors summarised in Table 1 should be considered. A full discussion with the patient is necessary in order to explain the benefits and risks of corticosteroid treatment. A patient information leaflet is now provided by the manufacturers of all systemic corticosteroid preparations. As emphasised by the recent publication by the Committee on the Safety of Medicines, advice to patients is the key to the safe use of long term systemic corticosteroids and it recommends discussing the following points with the patient: not to stop taking corticosteroids suddenly to see a doctor if they become unwell of the increased susceptibility to infections, especially chickenpox of the serious side effects that may occur to read and keep the patient information leaflet to always carry the steroid treatment card and to show it to any health professional involved in their treatment. In addition the following suggestions may help to minimise some side effects: a single morning dose early dietary modification--low calorie, low sodium, and high potassium awareness of possible errors of judgment on high doses. Once started on corticosteroids the patient should be regularly reviewed to assess the response to the treatment with adjustments to keep the dose at a minimum.

摘要

皮质类固醇的抗炎作用与其代谢作用无法分开,因为所有细胞都使用相同的糖皮质激素受体;因此,在开具皮质类固醇药物时,应采取措施尽量减少其副作用。显然,严重副作用的发生几率会随着治疗剂量和疗程的增加而上升,所以应给予控制疾病所需的最小剂量。在开始长期使用皮质类固醇治疗之前,应考虑表1中总结的因素。必须与患者进行充分讨论,以解释皮质类固醇治疗的益处和风险。现在,所有全身性皮质类固醇制剂的制造商都会提供一份患者信息手册。正如药品安全委员会最近发布的文件所强调的,向患者提供建议是安全使用长期全身性皮质类固醇的关键,该委员会建议与患者讨论以下几点:不要突然停止服用皮质类固醇;如果身体不适要去看医生;注意感染易感性增加,尤其是水痘;了解可能出现的严重副作用;阅读并保存患者信息手册;始终携带类固醇治疗卡,并向参与其治疗的任何医护人员出示。此外,以下建议可能有助于尽量减少一些副作用:早晨单次给药;早期调整饮食——低热量、低钠和高钾;意识到高剂量时可能出现的判断失误。一旦开始使用皮质类固醇,应对患者进行定期复查,以评估治疗反应,并进行调整以使剂量保持在最低水平。

相似文献

1
Systemic corticosteroid therapy--side effects and their management.
Br J Ophthalmol. 1998 Jun;82(6):704-8. doi: 10.1136/bjo.82.6.704.
2
Complications of corticosteroid therapy.
Am J Dis Child. 1978 Aug;132(8):806-10. doi: 10.1001/archpedi.1978.02120330078018.
4
Adverse effects of corticosteroids: II. Systemic.
Clin Dermatol. 1986 Jan-Mar;4(1):161-9. doi: 10.1016/0738-081x(86)90020-9.
5
Prevention and treatment of systemic glucocorticoid side effects.
Int J Dermatol. 2010 Mar;49(3):239-48. doi: 10.1111/j.1365-4632.2009.04322.x.
6
Side-effects of corticosteroid agents.
Med J Aust. 1986 Feb 3;144(3):139-42.
7
Inhaled corticosteroids in childhood asthma.
Aust Fam Physician. 1993 Dec;22(12):2163-7.
8
Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review.
Clin Ther. 2017 Nov;39(11):2216-2229. doi: 10.1016/j.clinthera.2017.09.011. Epub 2017 Oct 19.
9
The risks of systemic corticosteroid use.
Dermatol Clin. 1998 Apr;16(2):277-88. doi: 10.1016/s0733-8635(05)70010-3.
10
Chronic antiepileptic toxicity: a review.
Epilepsia. 1975 Jun;16(2):319-52. doi: 10.1111/j.1528-1157.1975.tb06062.x.

引用本文的文献

2
Anti-inflammatory drugs as potential antimicrobial agents: a review.
Front Pharmacol. 2025 Apr 8;16:1557333. doi: 10.3389/fphar.2025.1557333. eCollection 2025.
4
The history of uveitis: from antiquity to the present day.
Eye (Lond). 2025 Feb;39(3):488-491. doi: 10.1038/s41433-024-03519-x. Epub 2024 Dec 4.
7
TMX1, a disulfide oxidoreductase, is necessary for T cell function through regulation of CD3ζ.
bioRxiv. 2024 Sep 24:2024.09.22.614388. doi: 10.1101/2024.09.22.614388.
8
NSAIDs between past and present; a long journey towards an ideal COX-2 inhibitor lead.
RSC Adv. 2024 Sep 25;14(42):30647-30661. doi: 10.1039/d4ra04686b. eCollection 2024 Sep 24.
9
Awareness of Side Effects of Corticosteroids among Users and Nonusers in Saudi Arabia.
J Pharm Bioallied Sci. 2024 Apr;16(Suppl 2):S1612-S1618. doi: 10.4103/jpbs.jpbs_925_23. Epub 2024 Apr 16.

本文引用的文献

1
Tuberculosis occurring in association with corticosteroid treatment.
Tubercle. 1962 Mar;43:55-60. doi: 10.1016/s0041-3879(62)80048-8.
2
Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.
N Engl J Med. 1997 Sep 4;337(10):670-6. doi: 10.1056/NEJM199709043371003.
3
Testosterone concentrations in men on chronic glucocorticosteroid therapy.
J R Coll Physicians Lond. 1997 Mar-Apr;31(2):168-70.
4
Hormone replacement therapy for all? Universal prescription is desirable.
BMJ. 1996 Aug 10;313(7053):350-1. doi: 10.1136/bmj.313.7053.350.
5
Sleep disorders. Steroids cause sleep disturbance.
BMJ. 1993 May 29;306(6890):1477-8. doi: 10.1136/bmj.306.6890.1477-d.
6
Shift in age in chickenpox.
Lancet. 1993 Jan 30;341(8840):308-9. doi: 10.1016/0140-6736(93)92663-e.
7
Avascular necrosis of the hip.
Br J Hosp Med. 1994;51(6):275-80.
8
Corticosteroids and tuberculosis.
Respir Med. 1994 Sep;88(8):561-5. doi: 10.1016/s0954-6111(05)80002-2.
9
Near fatal chickenpox during prednisolone treatment.
BMJ. 1994 Oct 22;309(6961):1069-70. doi: 10.1136/bmj.309.6961.1069.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验